nach oben

Reactions Weekly

Erschienen in:

01.03.2020 | Case report

Antivirals/immunosuppressants

Leucopenia, fatigue and oedema following off-label use of letermovir, and CMV viraemia: 9 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

There is a discrepancy regarding the drug administered to patient no.8. As per figure 1, the patient received ganciclovir, but as per table 1, the patient received valganciclovir. However, we have considered data as per table 1.

Aryal S, et al. Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients. Transplant Infectious Disease 21: No. 6, Dec 2019. Available from: URL: http://doi.org/10.1111/tid.13166

Titel: Antivirals/immunosuppressants
Leucopenia, fatigue and oedema following off-label use of letermovir, and CMV viraemia: 9 case reports
Publikationsdatum: 01.03.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-75831-4

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Antivirals/immunosuppressants

Leucopenia, fatigue and oedema following off-label use of letermovir, and CMV viraemia: 9 case reports

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Norepinephrine/plasma

Deferiprone

Vancomycin

Ketoconazole

Immune globulin

Ipilimumab/nivolumab